Full Breakdown
Texas Rangers Re-Sign Josh Sborz to Minor-League Deal
1/21/2026, 4:37:00 AM
Overview of the Signing
On January 20, 2026, the Texas Rangers announced the signing of right-handed relief pitcher Josh Sborz to a minor-league contract that includes an invitation to major-league spring training. This marks Sborz's return to the organization after spending the previous five seasons with the team.
Background on Josh Sborz
Josh Sborz, 32, had a notable role in the Rangers' 2023 World Series victory, where he recorded the final out against the Arizona Diamondbacks. Throughout his six-year major league career, Sborz has maintained a 4.96 ERA (3.94 FIP) and a 1.33 WHIP, with 193 strikeouts over 163 1/3 innings. However, he missed the entire 2025 season due to recovery from shoulder surgery. Prior to his surgery, Sborz faced challenges with a right rotator cuff strain and shoulder fatigue during the 2024 season, limiting his performance.
Recent Transactions and Team Dynamics
The Rangers also signed relief pitcher Jakob Junis to a one-year, $4 million deal, necessitating the designation of pitcher Dom Hamel for assignment to make room on the 40-man roster. Sborz's signing comes amid significant changes in the Rangers' roster, as several key players from their 2023 championship team, including second baseman Marcus Semien and outfielder Adolis García, have departed. Despite these changes, Sborz's past postseason success may provide him an opportunity to compete for a spot in the Rangers' bullpen.
Performance and Recovery
Sborz's performance in the 2023 postseason was exceptional, as he posted a 0.75 ERA over 12 innings, allowing only one earned run. However, his recovery from shoulder surgery has been slow, with a 5.25 ERA in 12 minor league rehab appearances in 2025, where he struggled with velocity. As he prepares for spring training, Sborz aims to demonstrate his health and regain a position in the Rangers' bullpen.
Official Statements & Responses
The Texas Rangers have expressed optimism about Sborz's return, highlighting his previous contributions to the team. The organization is keen to see if he can reclaim his form and contribute effectively to the bullpen, especially given the uncertainty surrounding other relief roles.
Criticism & Opposition
Despite the positive outlook from the Rangers, some analysts remain skeptical about Sborz's ability to return to form after a significant injury layoff. Concerns about his velocity and overall effectiveness in the upcoming season have been raised, particularly given the competitive nature of the Rangers' bullpen.
What's Next
As spring training approaches, Sborz will have the opportunity to showcase his recovery and compete for a spot in the Rangers' bullpen. The team's decision-making regarding bullpen roles will be closely monitored, especially with the addition of Junis and the departure of other key players.
